Antonaci, Laura
 Distribuzione geografica
Continente #
NA - Nord America 666
EU - Europa 470
AS - Asia 233
SA - Sud America 6
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.380
Nazione #
US - Stati Uniti d'America 651
SE - Svezia 146
IT - Italia 119
SG - Singapore 111
IE - Irlanda 56
CN - Cina 46
DE - Germania 37
FR - Francia 36
ID - Indonesia 32
RU - Federazione Russa 18
FI - Finlandia 13
IR - Iran 10
RO - Romania 10
GB - Regno Unito 9
BE - Belgio 8
CA - Canada 8
IN - India 8
NL - Olanda 6
JP - Giappone 5
PA - Panama 5
TR - Turchia 5
BR - Brasile 4
CH - Svizzera 4
IL - Israele 4
KR - Corea 3
HK - Hong Kong 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
LT - Lituania 1
OM - Oman 1
UA - Ucraina 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.380
Città #
Chandler 190
Singapore 93
Ashburn 87
New York 52
Dublin 42
Jakarta 32
Marseille 24
Rome 24
Princeton 21
Boston 20
Milan 19
San Mateo 19
Moscow 13
Helsinki 12
Ann Arbor 10
Munich 10
Bremen 9
Palermo 9
Beijing 8
Los Angeles 8
Brussels 7
Wilmington 7
Menlo Park 6
Fairfield 5
Falkenstein 5
Kish 5
Seattle 5
Washington 5
Paris 4
Redwood City 4
Shanghai 4
São Paulo 4
Toronto 4
Amsterdam 3
Andover 3
Augusta 3
Boardman 3
Changsha 3
Chicago 3
Grottaferrata 3
Houston 3
London 3
Norwalk 3
Redmond 3
Seoul 3
West Chester 3
Woodbridge 3
Ancona 2
Balıkesir 2
Bari 2
Berlin 2
Busto Arsizio 2
Chongqing 2
Krakow 2
Leawood 2
Messina 2
Mexico City 2
Mountain View 2
Nanjing 2
Ottawa 2
Parma 2
Pasadena 2
Perm 2
Perugia 2
Pune 2
Saint-Fons 2
Salò 2
Turin 2
Viterbo 2
York 2
Abidjan 1
Almaty 1
Anaheim 1
Antwerpen 1
Ardabil 1
Athens 1
Aversa 1
Bern 1
Brescia 1
Bristol 1
Brno 1
Bryanston 1
Cattolica 1
Chieti 1
Columbus 1
Dearborn 1
Delianuova 1
Dhaka 1
Dubai 1
Erlangen 1
Freiburg 1
Grugliasco 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Hebei 1
Hong Kong 1
Lappeenranta 1
Las Vegas 1
Manchester 1
Totale 885
Nome #
Predominant distal muscle involvement in spinal muscular atrophy 87
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 76
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 72
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients 69
Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy? 67
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 65
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 60
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 59
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 57
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy 54
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 53
Clinical Variability in Spinal Muscular Atrophy Type III. 51
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy 51
P.222Long term progression in type II spinal muscular atrophy: a retrospective observational study 50
Patient and parent oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in SMA. Rome, 13 July 2019 50
Development of an academic disease registry for spinal muscular atrophy 48
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 45
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 44
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 42
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 40
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 36
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey? 35
Sleep disorders in spinal muscular atrophy 34
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome? 31
Long term follow-up of scoliosis progression in type II SMA patients 24
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 23
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (Neurology and Therapy, (2023), 12, 2, (543-557), 10.1007/s40120-023-00444-1) 21
New therapies for spinal muscular atrophy: where we stand and what is next 21
Early treatment of type II SMA slows rate of progression of scoliosis 15
Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study 14
Caregivers’ Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study 12
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment? 11
Totale 1.417
Categoria #
all - tutte 9.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 1 1 0 0 10 2
2020/202119 2 0 0 0 0 4 5 0 0 3 5 0
2021/2022241 14 4 5 44 18 8 6 31 18 16 38 39
2022/2023533 50 78 31 86 29 66 30 49 72 5 20 17
2023/2024372 7 79 11 34 11 77 28 23 1 29 33 39
2024/2025227 12 14 51 41 69 40 0 0 0 0 0 0
Totale 1.417